Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study

Table 7 Treatment outcome in smear-positive pulmonary TB patients at end of initial ATT

TREATMENT OUTCOME number (percent)	HIV + (n = 52)	HIV- (n = 105)	P-value
*Treatment success* ⁺	*36 (69.2)*	*100 (95.2)*	*<0.001*
Treatment completed ^{^}	6 (11.5)	5 (4.8)
Cure	30 (57.7)	95 (90.5)
Treatment failure	2 (3.8)	2 (1.9)
Lost to follow-up	8 (15.4)	2 (1.9)
Death	6 (11.5)	1 (1.0)

⁺ Sum of cure and treatment completed.
^{^} These patients were either diagnosed by bronchoscopy and smear positive aspirate, or unable to produce sputum to provide evidence of sputum conversion and therefore cure, but had clinical and radiological resolution at end of treatment.

ISSN: 1471-2334